Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) E10: ¥0.35 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603811 Zhejiang Cheng Yi Pharmaceutical Co Ltd SHSE:603811
85 GF Score
Price ¥7.43
GF Value ¥8.45
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Zhejiang Cheng Yi Pharmaceutical Co E10?

Zhejiang Cheng Yi Pharmaceutical Co SHSE:603811 +3.05% 85 E10 is ¥0.35 as of Mar. 2026. GuruFocus rates SHSE:603811 with a GF Score™ of 85/100 and a GF Value™ of ¥8.45 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Zhejiang Cheng Yi Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was ¥0.100. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.35 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Zhejiang Cheng Yi Pharmaceutical Co's average E10 Growth Rate was 6.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-07), Zhejiang Cheng Yi Pharmaceutical Co's current stock price is ¥7.43. Zhejiang Cheng Yi Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was ¥0.35. Zhejiang Cheng Yi Pharmaceutical Co's Shiller PE Ratio of today is 21.23.

During the past 13 years, the highest Shiller PE Ratio of Zhejiang Cheng Yi Pharmaceutical Co was 35.95. The lowest was 14.01. And the median was 20.85.


Zhejiang Cheng Yi Pharmaceutical Co  (SHSE:603811) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Zhejiang Cheng Yi Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=7.43/0.35
=21.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Zhejiang Cheng Yi Pharmaceutical Co was 35.95. The lowest was 14.01. And the median was 20.85.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Zhejiang Cheng Yi Pharmaceutical Co E10 Related Terms


Zhejiang Cheng Yi Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Zhejiang Cheng Yi Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Cheng Yi Pharmaceutical Co E10 Chart

Zhejiang Cheng Yi Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.32 0.34

Zhejiang Cheng Yi Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.33 0.33 0.34 0.35

SHSE:603811 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Cheng Yi Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Cheng Yi Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Cheng Yi Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Cheng Yi Pharmaceutical Co's Shiller PE Ratio falls into.


SHSE:603811
85GF Score
Zhejiang Cheng Yi Pharmaceutical Co Ltd SHSE:603811
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Cheng Yi Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhejiang Cheng Yi Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.1/116.3033*116.3033
=0.100

Current CPI (Mar. 2026) = 116.3033.

Zhejiang Cheng Yi Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.063 101.400 0.072
201609 0.035 102.400 0.040
201612 0.067 102.600 0.076
201703 0.041 103.200 0.046
201706 0.033 103.100 0.037
201709 0.033 104.100 0.037
201712 0.052 104.500 0.058
201803 0.055 105.300 0.061
201806 0.083 104.900 0.092
201809 0.081 106.600 0.088
201812 0.056 106.500 0.061
201903 0.052 107.700 0.056
201906 0.096 107.700 0.104
201909 0.095 109.800 0.101
201912 0.070 111.200 0.073
202003 0.055 112.300 0.057
202006 0.083 110.400 0.087
202009 0.087 111.700 0.091
202012 0.138 111.500 0.144
202103 0.102 112.662 0.105
202106 0.071 111.769 0.074
202109 0.087 112.215 0.090
202112 0.112 113.108 0.115
202203 0.061 114.335 0.062
202206 0.082 114.558 0.083
202209 0.079 115.339 0.080
202212 0.129 115.116 0.130
202303 0.086 115.116 0.087
202306 0.114 114.558 0.116
202309 0.050 115.339 0.050
202312 0.107 114.781 0.108
202403 0.071 115.227 0.072
202406 0.093 114.781 0.094
202409 0.093 115.785 0.093
202412 0.179 114.893 0.181
202503 0.100 115.116 0.101
202506 0.150 114.907 0.152
202509 0.071 115.471 0.072
202512 0.114 115.832 0.114
202603 0.100 116.303 0.100

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥0.35 mean?
Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) has a E10 of ¥0.35 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Zhejiang Cheng Yi Pharmaceutical Co and its competitors.
Is Zhejiang Cheng Yi Pharmaceutical Co's E10 too high?
Zhejiang Cheng Yi Pharmaceutical Co's current E10 is ¥0.35. Overall, Zhejiang Cheng Yi Pharmaceutical Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Cheng Yi Pharmaceutical Co's E10 compare to ZTS?
Zhejiang Cheng Yi Pharmaceutical Co's E10 of ¥0.35 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Zhejiang Cheng Yi Pharmaceutical Co and its competitors. Zhejiang Cheng Yi Pharmaceutical Co's current E10 is ¥0.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Cheng Yi Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥8.45, compared to a current price of ¥7.43 — trading 12.1% below its estimated fair value. The current E10 is ¥0.35. Zhejiang Cheng Yi Pharmaceutical Co's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811), the current E10 is ¥0.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Cheng Yi Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥7.43 is trading 12.1% below its estimated GF Value™ of ¥8.45. GuruFocus considers Zhejiang Cheng Yi Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:603811:

  • E10: ¥0.35
  • GF Value™: ¥8.45 vs. price of ¥7.43 (12.1% below fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the SHSE:603811 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhejiang Cheng Yi Pharmaceutical Co Business Description

Address Lane 988, Shenhong Road, 7th Floor, No. 9, Building 20, Fuli Yuedu, Minhang District, Shanghai, CHN, 201100
Zhejiang Cheng Yi Pharmaceutical Co Ltd is a pharmaceutical company that produces capsules, injections, tablets, APIs, and pharmaceutical intermediates in China. Its main products include glucosamine hydrochloride raw materials and preparations, torasemide injection and capsules, Gastrodin raw materials, ribavirin and purine raw materials, and so on.
85GF Score

Get the complete analysis for SHSE:603811

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥7.43
Price
¥8.45
GF Value